ABSTRACT. The molecular forms of lactoferrin (LF) were of the infant (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . Recent studies demonstrate that the urinary examined in stools and urine collected at 2.5 or 5 wk of excretion of IgA (1 1, 12), total secretory component (12), and age from very low birth wt infants fed either a cow's milk LF (12) was greater in human milk as compared to cow's milkformula or a fortified human milk preparation. LF was not fed infants. Those findings were particularly germane because found by Western blotting in excreta from infants fed cow's urine is a secretion whose formation is far removed from direct milk. In contrast, intact and fragmented forms of I F were contact with ingested human milk. In one report (12), prelimidetected in stools and concentrated urine of each infant nary evidence was presented that several fragments, as well as who received human milk. Only intact LF was detected in intact LF, were excreted in the urine of VLBW infants who were the fortified human milk preparation, whereas many types fed human milk. In this investigation, we sought to ascertain of LF fragments were present in the stools and urine. The whether these molecular fragments of LF in the urine of those approximate molecular wt of the most prominent fragments VLBW infants originated in the gastrointestinal tract. Therefore, were 44, 38, 34, and 32 kD. However, the stools also we examined stools as well as urine for these fragments from displayed lower molecular wt fragments that were not VLBW infants fed human milk. In addition, we attempted to found in urines of those infants. The LF fragments in those determine whether the fragments may contribute to the quantiexcreta were similar in size to those produced in vitro by tative measurement of LF in those excreta, and whether the limited digestion of apo-LF with trypsin. Furthermore, fragments are created by the action of certain enzymes found in fragments produced by in vitro proteolysis were immuno-the digestive tract. reactive in an ELISA for LF. Thus, the fragments of LF in stools of very low birth wt infants fed human milk appeared to be produced by in vivo proteolysis, and the
excreta were similar in size to those produced in vitro by tative measurement of LF in those excreta, and whether the limited digestion of apo-LF with trypsin. Furthermore, fragments are created by the action of certain enzymes found in fragments produced by in vitro proteolysis were immuno-the digestive tract. reactive in an ELISA for LF. Thus, the fragments of LF in stools of very low birth wt infants fed human milk appeared to be produced by in vivo proteolysis, and the
MATERIALS AND METHODS
close resemblance between the LF fragments in the stools and urine suggests that the urinary LF fragments origiStudy design.The study was approved by the institutional nated in the gastrointestinal tract. It remains unclear, review boards of both institutions. Two groups of VLBW infants however, whether the whole LF molecules that were frag-from the same hospital population were investigated (12, 13) . mented were derived solely from ingested LF in human One infant received CMF (Similac PM 60140 or Similac 24, milk or in part from LF produced by the infant in response Ross Laboratories, Columbus, OH) and the second received to human milk feedings. (Pediatr Res 27: 252-255, 1990) FHM prepared daily by adding pasteurized, lyophilized mature donor milk to fresh maternal milk as previously described (12, Abbreviations 13 (12, 13) . Stools and urine were collected continuously during 96-h balance periods at 2.5 and 5 wk of age and the specimens were stored at -20°C until analyzed. Recently, there has been an increased interest in the effects of SDS-PAGE-Western blotting.The molecular sizes of LF in the human milk upon the immunologic status of the recipient infant. FHM, stools, and urine from 15 infants fed CMF and 15 infants In addition to the direct protective effects of immuno~ogic factors fed FHM were examined by Western blotting (14) . The mol wt in the recipient's gastrointestinal tract (1, 21 , certain studies standards (Bethesda Research Laboratories Life Technologies, suggest that some defense agents in the milk may be abs~rbed Inc., Gaithersburg, MD) in these experiments were myosin (200 from the gastrointestinal tract or that other agents in human kD), phosphorylase B (97 kD), BSA (68 kD), ovalbumin (43 milk may speed the development of the n~ucosal defense system kD), carbonic anhydrase (27 kD), P-lactoglobulin (1 8 kD), and volumes of the standard nonreducing SDS-sample buffer and boiled for 2 min. The mixture (100 pL) was applied to the gel well and electrophoresed for 1 h at 20 mA and then for 3 h at 30 mA. The proteins in the gels were transferred electrophoretically to nitrocellulose sheets. The sheets were blocked with gelatin (3%), treated with rabbit polyclonal antisera to human LF (1 :250; Dako Corporation, Santa Barbara, CA), and incubated with goat antisera to rabbit IgG conjugated to horseradish peroxidase (1:1500; Bio-Rad, Chemical Division, Richmond, CA). After washing, bound enzyme was detected by applying chloronaphthol(60 mg) in Tris saline buffer alld hydrogen peroxide (100 pL of a 30% solution) in methyl alcohol (20 mL) to the sheets. The distances of migration of the protein standards were measured. Those measurements were logarithmically transformed to achieve a linear relationship between distance of migration and size of the mol wt standards and purified LF. The approximate molecular sizes of the LF fragments were estimated by plotting the log of the distance of migration of each fragment band on the standard graphs. As little as 3.2 ng/pL of purified apo-or difenic LF were detected by this method.
Fragments of human LF produced in vitro. Apo-LF was produced by dialyzing human LF (Sigma, no. L-8010) first against an acetic acid/sodium acetate solution (pH 4) and then against water. OD readings obtained at 465 nm (Gilford Instrument Laboratories, Inc., Oberlin, OH) or staining of Western blots with 3-(2-pyridy1)-5,6-bis (2-(5-furylsulfonic acid))-1,2,4 triazine disodium salt (Ferene S; Sigma) (15) revealed no bound iron. Difenic LF was produced by incubating human LF (Sigma) with 1 mM of a femc nitrilotriacetic acid complex and 1 M NaHC03 overnight at 25°C. Bound iron was detected in those preparations by spectrophotometry or staining with Ferene S.
Human apo-LF or difemc LF was partially digested with bovine pancreatic trypsin (Sigma, no. T-8128, 1050 BAEE U/ mg protein) or a mixture of porcine pancreatic trypsin and chymotrypsin (Sigma, no. T-8253, 10,000-13,000 BAEE U/mg protein). Enzyme to substrate ratios ranging from 1: 10 to 1:100 were used. After a 4-h incubation, reactions were stopped with a soybean tryptic inhibitor (Sigma, no. T-9003; 1.0 mg inhibits 1.25 mg trypsin). LF fragments were then detected by Western blotting.
Detection of LF fragments by ELISA. Apo-LF treated with trypsin (Sigma, no. T-8 128; substrate to enzyme ratio, 100: 1) for 4 h at 37°C and then with the soybean trypsin inhibitor produced a preparation that contained six to eight fragments but no intact LF. The amount of immunoreactive LF in the trypsinized preparation was quantified by ELISA method and compared to equal amounts of purified LF (4.0, 1 .O, 0.25, 0.06, or 0.015 pg/mL). The binding antibodies were polyclonal rabbit antibodies (Dako Corporation, Santa Barbara, CA; 3 pg/mL) and the antibody detector was a peroxidase conjugated, affinity-purifi rabbit antihuman LF (Accurate Chemical and Scientific Corporation, Westbury, NY; JZH-35 15, 1:25,000). Negative controls consisted of trypsin per se or trypsin and antitrypsin, but no LF. As little as 0.7 ng of purified apo-or diferric LF were detected by ELISA. We also tested whether LF fragments could be detected in the presence of intact LF. Native LF (2 pg/mL) was mixed with apo-LF (2 pg/mL) that had been treated with trypsin (substrate to enzyme ratio, 100: 1). Five experiments were performed. In each case, the amounts of immunoreactive LF in the intact LF, trypsinized LF, or mixtures of native and trypsinized LF were measured by ELISA. The predicted final concentrations were calculated by adding the concentrations of intact LF (2 pg/mL) to the amount measured in the LF fragment preparations. These predicted values were then compared to the measurements of immunoreactive LF in the mixtures of apo-LF and trypsinized LF.
No human LF was detected in the CMF and only the native (80 kD) form of LF was found in human milk preparations used in these feeding experiments (Fig. 1) . No LF was detected by Western blotting in the excreta of the infants who were fed CMF, whereas both native and lower molecular forms of LF were detected in the stools and urines of each of the infants who received FHM (Figs. 1 and 2) . As many as six to eight, and as few as three, fragments were detected in those excreta. The approximate molecular mass of the most prominent fragments A B C D E F Fig. 1 . Representative Western blotting of stools and urine for LF. The lanes are as follows: A, human LF; B, human milk; C, stool from an infant fed CMF; D, concentrated urine from a CMF-fed infant; E, stool from a FHM-fed infant; and F, concentrated urine from a FHM infant. Mol wt standards were also subjected to Western blotting but were not included because of the low intensity of staining of the bands. were 44, 38, 34, and 32 kD. The molecular moieties of LF in the 5 stools and urine from the same infant were usually similar, although additional smaller fragments were often found in the stools (Fig. 2) . No differences were found in the forms of LF in 4 excreta obtained at 2.5 or 5 wk of age.
E
The sizes of the LF fragments in the stools and urine from the $ infants fed FHM were similar to certain fragments generated bylimited digestion of apo-LF with trypsin (Fig. 3) . Similar frag-. ;
ments were produced by treating apo-LF with trypsin and chy- (Fig. 4) . The results of the studies that were designed to ascertain whether LF fragments could be detected in the presence of intact LF were as follows. The mean + SD of the predicted amount of immunoreactive LF in the mixtures was 3.27 + 0.36 pg/mL, whereas 2.88 + 0.66 pg/mL (p = 0.05) was detected.
Similar experimental results were obtained when trypsinized difemc LF was mixed with intact LF (results not shown).
DISCUSSION
LF, a single-chain glycoprotein, is composed of 703 amino acids arranged in two lobes, each of which has two domains and one site for binding Fe3+ (16) . The N-lobe (residues 1-332) and the C-lobe (residues 344-703) are connected by a three-turn helix (residues 333-343) (16) . When Fe3+ is bound, the protein be- Mol wt standards were also subjected to Western blotting but were not included in the illustration because of the low intensity of staining of the bands. Fig. 4 . The immunoreactivity of LF fragments produced in vitro by partial digestion with trypsin (substrate to enzyme ratio, 1: 100). Immunoreactive LF was quantified in the following preparations by ELISA: A, purified LF (4 pg/mL); B, purified human LF (4 &mL) treated with trypsin and then with a soybean antitrypsin; C, trypsin mixed with soybean antitrypsin (negative controls). No SD bars were included for the measurement of purified LF ( A ) or for the measurement of trypsin and the soybean aniitrypsin (C) because a predetermined amount of purified LF (4 pg/mL) was used and no immunoreactive LF was detected in the negative controls (C). No immunoreactive LF was detected with trypsin per se (data not shown).
comes more compact as the domains of each lobe close over the iron atom. Consequently, the protein becomes less susceptible to enzymatic digestion. Indeed, when diferric human LF is subjected to limited digestion with trypsin, two major fragments that correspond to the N-lobe (30 kD) and C-lobe (50 kD) are produced (17) . Further, tryptic digestion of the N-lobe leads to an 18.5-kD glycopeptide that includes the second domain of that lobe (1 8) . The N-lobe of the molecule is pepsin sensitive, whereas the C-lobe remains intact after treatment with that enzyme (19) . Many more molecular fragments are found, however, when apo-LF is partially digested with trypsin or chymotrypsin (20) .
In this study, we found that fragments, as well as the native form of LF, were excreted in the stools and urine of VLBW infants fed a FHM preparation. LF fragments have previously been demonstrated in stools of breast-fed infants by SDS-PAGE (2 1). A greater number of LF fragments was found in the current study, possibly because a more sensitive detection system, e.g.
Western blotting, was used or because the maturity of subjects that were investigated was different. A 20-kD fragment of LF that immunologically cross-reacts with bovine P-lactoglobulin has recently been found in human milk (22) . That finding could not account for the several types of LF fragments found in the stools of our infants fed FHM. Furthermore, no LF fragments were detected in the human milk used in these feeding experiments. The discrepancy, however, may be due to differences in the specificities of the antisera used in the two studies. The fragments of LF in the stools of the VLBW infants most closely resembled those produced in vitro by partial digestion of apo-LF (20) . Inasmuch as only intact LF was demonstrated in the FHM fed to the infants and most LF in human milk is in the apo form (23) , the fragments of LF in the stools were most likely produced by partial digestion of apo-LF in the gastrointestinal tract of the recipient infants. It remains unclear, however, what proportion of the LF substrate originated from the FHM or was produced by the infant in response to human milk feedings (1 0, 12).
It was surprising that similar LF fragments were found in the urines of VLBW infants fed human milk. Inasmuch as proteolytic enzymes are not produced in the normal urinary tract and it was improbable that the urinary tract of each infant was colonized with protease-producing bacteria, it seems likely that the LF fragments originated in the gastrointestinal tract. It is of interest that somewhat smaller fragments were found in the stools possibly because of bacterial proteolysis in the lower intestinal tract of the recipient. It is also possible that some of the smaller fragments in the stools were generated because of in vitro proteolysis of the specimens. Furthermore, if the smaller fragments were produced in the intestinal tract and then were absorbed into the systemic circulation, they may have been cleared by the reticuloendothelial system before being filtered by the kidney. Finally, the way that the larger fragments of LF would be transported from the more proximal parts of the intestinal tract to the systemic circulation and hence to the urinary tract remains unclear.
Our study demonstrates that some epitopes of apo-LF are retained in fragments of that protein and the results suggest that the fragments along with intact LF may be detected in the excreta of VLBW infants fed human milk. The molecular structure of the fragments, the amounts of them in those excreta, and the retention of the biologic functions of intact LF (24-32) have not been established. Methods should be developed to distinguish quantitatively between the excretion of intact LF and its fragments and to separate each of the fragments for further molecular and biologic studies. This would further ascertain the fate and function of ingested LF or of LF produced in the alimentary tract of young infants.
A possible analogy to the occurrence of LF fragments in these infants is the generation of 0-casomorphins in the gastrointestinal tract of newborn calves fed bovine casein (33) . In vivo enzymatic cleavage of ingested casein produces biologically active peptides released from larger nutrient or immunologic proteins by partial proteolysis that may be absorbed into the systemic circulation and may have significant effects upon the recipient infant (34) . That may be the case in respect to LF fragments in VLBW infants fed human milk.
Finally, it will be important to determine whether similar molecular fragments of LF occur in the excreta of mature, breastfed infants. Our preliminary findings indicate that is the case, but more extensive investigations will be required to definitively answer the question.
